Meeting of the Advisory Board on Radiation and Worker Health, National Institute for Occupational Safety and Health, 58379-58380 [2024-15797]

Download as PDF khammond on DSKJM1Z7X2PROD with NOTICES Federal Register / Vol. 89, No. 138 / Thursday, July 18, 2024 / Notices consumer perspectives and/or social and community aspects of immunization programs. DATES: Nominations for membership on the ACIP must be received no later than August 15, 2024. Packages received after this time will not be considered for the current membership cycle. ADDRESSES: All nominations must be completed online at https:// www.cdc.gov/vaccines/acip/apply-formembership/. FOR FURTHER INFORMATION CONTACT: Stephanie Thomas, Committee Management Specialist, Advisory Committee on Immunization Practices, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, 1600 Clifton Road NE, Mailstop H24–8, Atlanta, Georgia 30329–4027. Telephone: (404) 639–8836; Email: ACIP@cdc.gov. SUPPLEMENTARY INFORMATION: The Advisory Committee on Immunization Practices (ACIP) is charged with advising the Director, Centers for Disease Control and Prevention (CDC), on the use of immunizing agents. In addition, under 42 U.S.C. 1396s, the Committee is mandated to establish and periodically review and, as appropriate, revise the list of vaccines for administration to vaccine-eligible children through the Vaccines for Children program, along with schedules regarding dosing interval, dosage, and contraindications to administration of vaccines. Further, under applicable provisions of the Affordable Care Act and section 2713 of the Public Health Service Act and implementing regulations, immunization recommendations of ACIP that have been approved by the Director, CDC, and appear on CDC immunization schedules generally must be covered by applicable health plans. Nominations are being sought for individuals who have the expertise and qualifications necessary to contribute to the accomplishments of the committee’s objectives. Nominees will be selected based on expertise in the fields of immunization practices, multidisciplinary expertise in public health, expertise in the use of vaccines and immunologic agents in both clinical and preventive medicine, knowledge of vaccine development, evaluation, and vaccine delivery, or knowledge about consumer perspectives and/or social and community aspects of immunization programs. Federal employees will not be considered for membership. Members may be invited to serve for up to four-year terms. Selection of members is based on VerDate Sep<11>2014 16:47 Jul 17, 2024 Jkt 262001 candidates’ qualifications to contribute to the accomplishment of ACIP objectives (https://www.cdc.gov/ vaccines/acip/). HHS policy stipulates that committee membership be balanced in terms of points of view represented, and the committee’s function. Appointments shall be made without discrimination on the basis of age, race, ethnicity, gender, sexual orientation, gender identity, HIV status, disability, and cultural, religious, or socioeconomic status. Nominees must be U.S. citizens and cannot be full-time employees of the U.S. Government. Current participation on Federal workgroups or prior experience serving on a Federal advisory committee does not disqualify a candidate; however, HHS policy is to avoid excessive individual service on advisory committees and multiple committee memberships. Committee members are Special Government Employees, requiring the filing of financial disclosure reports at the beginning and annually during their terms. CDC reviews potential candidates for ACIP membership each year and provides a slate of nominees for consideration to the Secretary of HHS for final selection. HHS notifies selected candidates of their appointment near the start of the term in July 2025, or as soon as the HHS selection process is completed. Note that the need for different expertise varies from year to year and a candidate who is not selected in one year may be reconsidered in a subsequent year. SGE nominees must be U.S. citizens and cannot be full-time employees of the U.S. Government. Candidates should submit the following items: ■ Current curriculum vitae, including complete contact information (telephone numbers, mailing address, email address) ■ Two letters of recommendation from professional colleagues familiar with the candidate’s work. A maximum of four letters of recommendation will be accepted. Æ Letters of recommendation should not come from current ACIP members. Æ At least one letter of recommendation from person(s) not employed by HHS. Candidates may submit letter(s) from current HHS employees if they wish, but at least one letter must be submitted by a person not employed by an HHS agency (e.g., National Institutes of Health, Food and Drug Administration, Substance Abuse and Mental Health Services Administration, etc.). CDC employees should not provide letters of recommendation. PO 00000 Frm 00053 Fmt 4703 Sfmt 4703 58379 ■ A cover letter that includes the candidate’s statement of interest in serving on the ACIP, the qualifications and expertise that the candidate would bring, and written evidence to support how the candidate meets all relevant criteria. Nominations may be submitted by the candidate or by the person/organization recommending the candidate. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–15792 Filed 7–17–24; 8:45 am] BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Meeting of the Advisory Board on Radiation and Worker Health, National Institute for Occupational Safety and Health Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice of meeting. AGENCY: In accordance with the Federal Advisory Committee Act, the Centers for Disease Control and Prevention (CDC) announces the following meeting of the Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board). This is a virtual meeting. It is open to the public, with a public comment period. The public is also welcome to submit written comments in advance of the meeting, to the contact person listed in the addresses section below. The public is also welcome to listen to the meeting by joining the teleconference (information below), limited only by the number of audio conference lines available (150). DATES: The meeting will be held on August 7, 2024, from 11 a.m. to 6 p.m., EDT, and on August 8, 2024, from 11 a.m. to 1 p.m., EDT. A public comment session will be held on August 7, 2024, SUMMARY: E:\FR\FM\18JYN1.SGM 18JYN1 58380 Federal Register / Vol. 89, No. 138 / Thursday, July 18, 2024 / Notices at 5 p.m., EDT, and will conclude at 6 p.m., EDT, or following the final call for public comment, whichever comes first. Written comments must be received on or before August 5, 2024. ADDRESSES: You may submit comments by mail to: Rashaun Roberts, National Institute for Occupational Safety and Health, 1090 Tusculum Avenue, Mailstop C–24, Cincinnati, Ohio 45226. Meeting Information: The USA tollfree dial-in numbers are: +1 669 254 5252 US (San Jose); and +1 646 828 7666 US (New York). The meeting ID is: 160 6763 3819; the Passcode is: 98685439; and the Web conference by Zoom meeting connection is: https:// cdc.zoomgov.com/j/16067633819?pwd= RUdiYXlZZHFKanp JOHZrcGJIbTlaZz09. khammond on DSKJM1Z7X2PROD with NOTICES FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated Federal Official, National Institute for Occupational Safety & Health, Centers for Disease Control and Prevention, 1090 Tusculum Avenue, Mailstop C–24, Cincinnati, Ohio 45226, Telephone: (513) 533–6800; Toll Free 1 (800) 232– 4636; Email: ocas@cdc.gov. SUPPLEMENTARY INFORMATION: Background: The Advisory Board was established under the Energy Employees Occupational Illness Compensation Program Act of 2000 to advise the President on a variety of policy and technical functions required to implement and effectively manage the new compensation program. Key functions of the Advisory Board include providing advice on the development of probability of causation guidelines, that have been promulgated by the Department of Health and Human Services (HHS) as a final rule, advice on methods of dose reconstruction which have also been promulgated by HHS as a final rule; advice on the scientific validity and quality of dose estimation and reconstruction efforts being performed for purposes of the compensation program, and advice on petitions to add classes of workers to the Special Exposure Cohort (SEC). In December 2000, the President delegated responsibility for funding, staffing, and operating the Advisory Board to HHS, which subsequently delegated this authority to the CDC. NIOSH implements this responsibility for CDC. The charter was issued on August 3, 2001, renewed at appropriate intervals, and rechartered under Executive Order 13179 on March 22, 2024. Unless continued by the President the Board will terminate on September 30, 2025, consistent with E.O. 14109 of September 29, 2023. VerDate Sep<11>2014 16:47 Jul 17, 2024 Jkt 262001 Purpose: This Advisory Board is charged with (a) providing advice to the Secretary, HHS, on the development of guidelines under Executive Order 13179; (b) providing advice to the Secretary, HHS, on the scientific validity and quality of dose reconstruction efforts performed for this program; and (c) upon request by the Secretary, HHS, advising the Secretary on whether there is a class of employees at any Department of Energy (DOE) facility who were exposed to radiation but for whom it is not feasible to estimate their radiation dose, and on whether there is reasonable likelihood that such radiation doses may have endangered the health of members of this class. Matters to be Considered: The agenda will include discussions on the following: National Institute for Occupational Safety & Health Program Update; Department of Labor Program Update; Department of Energy Program Update; SEC Petitions Update; Procedures Review Finalization/ Document Approvals; Idaho National Lab; Savannah River Site, Pinellas Workgroup, and Subcommittee on Dose Reconstruction Review updates; a Board Work Session; and Board Correspondence review. Agenda items are subject to change as priorities dictate. For additional information, please contact Toll Free 1–800–232– 4636. The Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Office of Strategic Business Initiatives, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2024–15797 Filed 7–17–24; 8:45 am] BILLING CODE 4163–18–P PO 00000 Frm 00054 Fmt 4703 Sfmt 4703 DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Medicare & Medicaid Services [CMS–3456–FN] Medicare and Medicaid Programs: Application From The Joint Commission for Continued Approval of Its Ambulatory Surgical Center (ASC) Accreditation Program Centers for Medicare & Medicaid Services (CMS), HHS. ACTION: Notice. AGENCY: This notice announces our decision to approve The Joint Commission for continued recognition as a national accrediting organization for Ambulatory Surgical Centers that wish to participate in the Medicare or Medicaid programs. DATES: The decision announced in this notice is applicable September 1, 2024, to September 1, 2030. FOR FURTHER INFORMATION CONTACT: Caecilia Andrews (410) 786–2190. SUPPLEMENTARY INFORMATION: SUMMARY: I. Background Ambulatory Surgical Centers (ASCs) are distinct entities that operate exclusively for the purpose of furnishing outpatient surgical services to patients. Under the Medicare program, eligible beneficiaries may receive covered services from an ASC provided certain requirements are met. Section 1832(a)(2)(F)(i) of the Social Security Act (the Act) establishes distinct criteria for a facility seeking designation as an ASC. Regulations concerning provider agreements are at 42 CFR part 489 and those pertaining to activities relating to the survey and certification of facilities are at 42 CFR part 488. The regulations at 42 CFR part 416 specify the conditions that an ASC must meet in order to participate in the Medicare program, the scope of covered services, and the conditions for Medicare payment for ASCs. Generally, to enter into an agreement, an ASC must first be certified by a State survey agency (SA) as complying with the conditions or requirements set forth in part 416 of our Medicare regulations. Thereafter, the ASC is subject to regular surveys by an SA to determine whether it continues to meet these requirements. Section 1865(a)(1) of the Act provides that, if a provider entity demonstrates through accreditation by a Centers for Medicare & Medicaid Services (CMS) approved national accrediting organization (AO) that all applicable E:\FR\FM\18JYN1.SGM 18JYN1

Agencies

[Federal Register Volume 89, Number 138 (Thursday, July 18, 2024)]
[Notices]
[Pages 58379-58380]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-15797]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Meeting of the Advisory Board on Radiation and Worker Health, 
National Institute for Occupational Safety and Health

AGENCY: Centers for Disease Control and Prevention (CDC), Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, the 
Centers for Disease Control and Prevention (CDC) announces the 
following meeting of the Advisory Board on Radiation and Worker Health 
(ABRWH or the Advisory Board). This is a virtual meeting. It is open to 
the public, with a public comment period. The public is also welcome to 
submit written comments in advance of the meeting, to the contact 
person listed in the addresses section below. The public is also 
welcome to listen to the meeting by joining the teleconference 
(information below), limited only by the number of audio conference 
lines available (150).

DATES: The meeting will be held on August 7, 2024, from 11 a.m. to 6 
p.m., EDT, and on August 8, 2024, from 11 a.m. to 1 p.m., EDT. A public 
comment session will be held on August 7, 2024,

[[Page 58380]]

at 5 p.m., EDT, and will conclude at 6 p.m., EDT, or following the 
final call for public comment, whichever comes first.
    Written comments must be received on or before August 5, 2024.

ADDRESSES: You may submit comments by mail to: Rashaun Roberts, 
National Institute for Occupational Safety and Health, 1090 Tusculum 
Avenue, Mailstop C-24, Cincinnati, Ohio 45226.
    Meeting Information: The USA toll-free dial-in numbers are: +1 669 
254 5252 US (San Jose); and +1 646 828 7666 US (New York). The meeting 
ID is: 160 6763 3819; the Passcode is: 98685439; and the Web conference 
by Zoom meeting connection is: https://cdc.zoomgov.com/j/16067633819?pwd=RUdiYXlZZHFKanpJOHZrcGJIbTlaZz09.

FOR FURTHER INFORMATION CONTACT: Rashaun Roberts, Ph.D., Designated 
Federal Official, National Institute for Occupational Safety & Health, 
Centers for Disease Control and Prevention, 1090 Tusculum Avenue, 
Mailstop C-24, Cincinnati, Ohio 45226, Telephone: (513) 533-6800; Toll 
Free 1 (800) 232-4636; Email: [email protected].

SUPPLEMENTARY INFORMATION: 
    Background: The Advisory Board was established under the Energy 
Employees Occupational Illness Compensation Program Act of 2000 to 
advise the President on a variety of policy and technical functions 
required to implement and effectively manage the new compensation 
program. Key functions of the Advisory Board include providing advice 
on the development of probability of causation guidelines, that have 
been promulgated by the Department of Health and Human Services (HHS) 
as a final rule, advice on methods of dose reconstruction which have 
also been promulgated by HHS as a final rule; advice on the scientific 
validity and quality of dose estimation and reconstruction efforts 
being performed for purposes of the compensation program, and advice on 
petitions to add classes of workers to the Special Exposure Cohort 
(SEC). In December 2000, the President delegated responsibility for 
funding, staffing, and operating the Advisory Board to HHS, which 
subsequently delegated this authority to the CDC. NIOSH implements this 
responsibility for CDC.
    The charter was issued on August 3, 2001, renewed at appropriate 
intervals, and rechartered under Executive Order 13179 on March 22, 
2024. Unless continued by the President the Board will terminate on 
September 30, 2025, consistent with E.O. 14109 of September 29, 2023.
    Purpose: This Advisory Board is charged with (a) providing advice 
to the Secretary, HHS, on the development of guidelines under Executive 
Order 13179; (b) providing advice to the Secretary, HHS, on the 
scientific validity and quality of dose reconstruction efforts 
performed for this program; and (c) upon request by the Secretary, HHS, 
advising the Secretary on whether there is a class of employees at any 
Department of Energy (DOE) facility who were exposed to radiation but 
for whom it is not feasible to estimate their radiation dose, and on 
whether there is reasonable likelihood that such radiation doses may 
have endangered the health of members of this class.
    Matters to be Considered: The agenda will include discussions on 
the following: National Institute for Occupational Safety & Health 
Program Update; Department of Labor Program Update; Department of 
Energy Program Update; SEC Petitions Update; Procedures Review 
Finalization/Document Approvals; Idaho National Lab; Savannah River 
Site, Pinellas Workgroup, and Subcommittee on Dose Reconstruction 
Review updates; a Board Work Session; and Board Correspondence review. 
Agenda items are subject to change as priorities dictate. For 
additional information, please contact Toll Free 1-800-232-4636.
    The Director, Office of Strategic Business Initiatives, Office of 
the Chief Operating Officer, Centers for Disease Control and 
Prevention, has been delegated the authority to sign Federal Register 
notices pertaining to announcements of meetings and other committee 
management activities, for both the Centers for Disease Control and 
Prevention and the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Office of Strategic Business Initiatives, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2024-15797 Filed 7-17-24; 8:45 am]
BILLING CODE 4163-18-P


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.